GRAY MARY ANN 4
4 · RAPT Therapeutics, Inc. · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
RAPT Director Mary Ann Gray Receives 4,956 RSU Award
What Happened
Mary Ann Gray, a director of RAPT Therapeutics, received an award of 4,956 restricted stock units (RSUs) on January 30, 2026. The reported acquisition price is $0.00 (award/grant, code A), so no cash was paid. The RSUs represent a contingent right to one share of common stock per RSU and fully vest on the first anniversary of the grant (Jan 30, 2027).
Key Details
- Transaction date: 2026-01-30; Form 4 filed: 2026-02-02 (timely filing).
- Transaction type/code: Award/Grant (A). Price reported: $0.00; aggregate cash value shown as $0.
- Number of RSUs granted: 4,956.
- Vesting: Fully vests one year after grant date (per footnote).
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnote: Grant is the annual director RSU award under the issuer’s non-employee director compensation policy; each RSU converts to one share upon vesting.
Context: This is a routine director compensation award rather than an open-market purchase or sale. Such grants are common as part of board compensation and do not, by themselves, indicate a buy or sell signal.
Insider Transaction Report
Form 4
GRAY MARY ANN
Director
Transactions
- Award
Common Stock
[F1]2026-01-30+4,956→ 4,956 total
Footnotes (1)
- [F1]Represents the annual grant of restricted stock units ("RSUs") under the Issuer's Amended & Restated Non-Employee Director Compensation Policy, as currently in effect, which fully vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock upon vesting.
Signature
/s/ Rodney Young, Attorney-in-Fact|2026-02-02